Odyssey Health Reports Improved Losses Amid Financial Challenges in Q3 2025 Quarterly Report

Odyssey Health, Inc. (OTCBB: ODYY) has released its quarterly report for the period ended April 30, 2025, exhibiting various financials that highlight its operational achievements and challenges.

Key Highlights:

• Net Loss: The company reported a net loss of $251,743 for Q3 2025, an improvement compared to a loss of $842,341 in Q3 2024.
• Loss from Operations: Loss from operations decreased significantly from $372,371 in the previous year to $129,055 in the current quarter.
• Research Expenses: No research and development expenses were accrued this quarter, compared to $65,766 in Q3 2024.
• General and Administrative Expenses: Decreased by 63% to $117,274 from $320,888 year-over-year.
• Gain on Sale of Asset: Previously, a substantial gain on asset sale of $16,400,687 was recognized last year, which is absent this quarter.
• Stock-based Compensation: Decreased by 77% to $11,781, reflecting reduced compensation costs relative to previous high grants.
• Acquisition of Oragenics Stock: Valued at $97,149 as of April 30, 2025, down from $529,203 in July 2024.
• Accumulated Deficit: The total accumulated deficit has grown to $62,493,921 from $61,003,146 as of last year.

Financial Notes:

• Total Assets: Total assets have decreased from $586,146 as of July 31, 2024, to $164,508 as of April 30, 2025, indicating a reduced cash position and asset value.
• Total Liabilities: Current liabilities significantly rose to $6,867,290 compared to $5,919,895 last year, influenced by increased accounts payable and accrued wages.
• Cash Flow: The company utilized $299,193 in operating activities for the nine months ended April 30, 2025.
• Share Metrics: Reported a basic net loss per share of $(0.00) and diluted of $(0.00), with approximately 104.7 million shares used in calculations.

Positive Aspects:

• Substantial decrease in both operational and general expenses, indicating improved cost management.
• Reduction in net losses reflects better financial performance compared to previous quarters.

Negative Aspects:

• Continued operating losses and an increase in total liabilities pose a risk to long-term sustainability.
• Lack of revenue generation from products currently under development raises concerns about future cash flows.

Odyssey Health operates in a challenging environment as it seeks to develop its health technologies while managing costs. The improvement in loss figures provides some optimism; however, the ongoing financial obligations and necessity for further capital raises continue to present significant operational hurdles.